VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price was up 36.4% during mid-day trading on Saturday . The stock traded as high as C$0.17 and last traded at C$0.15. Approximately 1,722,555 shares changed hands during trading, an increase of 726% from the average daily volume of 208,641 shares. The stock had previously closed at C$0.11.
VentriPoint Diagnostics Trading Up 36.4%
The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The company has a fifty day moving average of C$0.13 and a 200-day moving average of C$0.12. The firm has a market capitalization of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- 3 Dividend Kings To Consider
- RH Stock Rockets on Surprise Profit and Tariff Shift
- 10 Best Airline Stocks to Buy
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Alphabet Enters a Bull Market: Is It Time to Buy?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
-inc-logo-1200x675.png?v=20210329140121&h=45&w=95&zc=2){kind=logo}
